Document Classification

Section Type: RESULTS

Text: During follow-up, 234 (12/100 patient-years) (ATP-III) and 178 (8/100 patient-years) (IDF) progressed to MS. MS at baseline had a borderline association with increased risk of CVD [ATP-III : hazard ratio (HR), 2. 56 ; 95 % confidence interval (CI), 0. 86-7. 60 ; P = 0. 095 ; IDF : HR, 2. 89 ; 95 % CI, 0. 98-8. 63 ; P = 0. 058] and was significantly associated with an increased risk of T2DM (ATP-III : HR, 4. 34 ; 95 % CI, 1. 83-10. 25 ; P = 0. 001 ; IDF : HR, 3. 33 ; 95 % CI, 1. 35-8. 17 ; P = 0. 009).